Inside Alzheimer's Disease: Mechanisms and Pathology Research

Added:

Plaque Origins
Tau Neurotoxicity
Cure Outlook

Plaque Origins

0:00
Playing Section
  • 1

    Amyloid beta plaques form key brain lesions.

  • 2

    Oligomers disrupt synaptic communication and plasticity.

Basic neuroanatomy, specifically the structure of neurons, synapses, and key brain regions like the hippocampus.
The fundamentals of protein synthesis, folding, and how misfolded proteins can disrupt cellular function.
The concept of cellular signaling and synaptic transmission, which is disrupted in neurodegenerative diseases.
An introductory understanding of the body's immune response, particularly the role of glial cells (microglia and astrocytes) in the central nervous system.
Pharmacological treatments and drug development strategies for Alzheimer's, such as monoclonal antibodies targeting beta-amyloid and tau.
Diagnostic methodologies, including neuroimaging techniques (PET, MRI) and fluid biomarkers (CSF and blood-based assays) used to detect early-stage pathology.
The genetic basis of Alzheimer's disease, including the role of risk-factor genes like APOE-e4 and causative mutations in APP, PSEN1, and PSEN2.
The societal, clinical, and ethical implications of early diagnosis, patient care, and clinical trials for neurodegenerative diseases.
559.8K views10.1Klikes4:20@NatureVideoChannelOriginal Release: 2017-01-03

Alzheimer's disease is characterized by the accumulation of amyloid beta plaques formed from misfolded amyloid precursor protein and neurofibrillary tangles composed of abnormal tau protein; amyloid beta oligomers disrupt synaptic communication and trigger microglial inflammation, while misfolded tau spreads between neurons through synapses, progressively damaging brain cells and impairing cognitive function.